Apremilast associated with improvement in LDL, obesity and diabetic A1c in PsA pts, especially in those with worse level
Tweet Content
Apremilast associated with improvement in LDL, obesity and diabetic A1c in PsA pts, especially in those with worse levels at baseline!
Can consider apremilast use in PsA with high burden of comorbid cardiometabolic diseases
@RheumNow #ACR23 Abs#1414 https://t.co/fL9UWcaZgG
Show on Archive Page
On
Display in Search Results
On
PDQ
Off